本則回應

• 新人標記此篇為：⭕ 含有正確訊息

  理由

  1.路透社報導屬實，報導原文有提到「該候選疫苗尚未完成臨床試驗，也沒有成效數據。」(The vaccine candidate has yet to finish clinical trials and no efficacy data is available）
  2.目前高端疫苗閱讀更多

  出處

  https://www.reuters.com/world/asia-pacif⋯s-covid-19-vaccine-candidate-2021-07-19/
  
  https://www.chinatimes.com/realtimenews/20210720005359-260408
  
  https://www.cdc.gov.tw/Bulletin/Detail/gzkfXTnBuktqDJ3BXhI54w?typeid=9

  Taiwan approves Medigen's COVID-19 vaccine candidate

  https://www.reuters.com/world/asia-pacific/taiwan-approves-production-medigens-covid-19-vaccine-candidate-2021-07-19/

  Taiwan's government on Monday approved the emergency use and production of Medigen Vaccine Biologics Corp's (6547.TWO) COVID-19 vaccine candidate, a major step in the island's plans to develop its own

  路透社也報導高端疫苗「未經臨床就獲准使用」 - 國際

  https://www.chinatimes.com/realtimenews/20210720005359-260408

  高端疫苗在進行三期試驗的情況，就通過了緊急授權使用，這創下了疫苗研發的奇特前例。路透社也做了相關報導，提到「該候選疫苗尚未完成臨床試驗，也沒有成效數據」(The vaccine candidate has yet to finish clinica

  衛福部核准高端MVC-COV1901新冠肺炎疫苗專案製造

  https://www.cdc.gov.tw/Bulletin/Detail/gzkfXTnBuktqDJ3BXhI54w?typeid=9